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Neural tube defects (NTDs) represent the most common class of structural 
congenital malformations in humans. While periconceptional supplementation with folic 
acid (FA) may prevent up to 70% of NTDs, a well-developed intervention strategy is 
required to address the remaining 30±% of NTDs that are non-responsive to folate 
intervention. During pregnancy, FA provides essential one carbon (1C) units for nucleotide 
and methyl group biosynthesis through folate mediated 1C metabolism to proper neural 
tube closure (NTC). Mitochondrial folate transporter (MFT, encoded by the SLC25A32 
gene) transports tetrahydrofolate (THF), the bioactive form of FA, into mitochondria. We 
characterized a novel folate mitochondrial transport mouse model by inactivating the 
Slc25a32 gene. Inactivation of the Slc25a32 gene resulted in embryo-fetal lethality, as the 
Slc25a32gt/gt fetuses die in utero by E12.5. Perturbation of the Slc25a32 allele exhibited 
abnormalities of NTC, resulting in fully penetrant NTDs of exencephaly and 
 v 
craniorachischisis in the Slc25a32gt/gt embryos, as well as an increased prevalence of 
craniofacial defects and a reduction in embryonic growth compared to the wild-type 
embryos. Maternal folic acid supplementation, 5-methyl-tetrahydrofolate (5-mTHF), was 
ineffective in reducing the prevalence of NTDs in Slc25a32gt/gt embryos. These NTDs were 
partially rescued by maternal supplementation with calcium formate, which is a 
downstream output product of the mitochondrial folate 1C pathway. This study proposed 
to utilize the Slc25a32 mouse model as a novel tool for studying the function FA in the 
mitochondria with respect to NTC, the mechanisms that underlie the failure of NTC in the 
mouse model of folate-resistant NTDs. 
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1 Introduction 
Neural tube defects (NTDs) are one of the most common structural congenital 
malformations in humans, resulting from failed closure of the neural tube. NTDs 
compromise over 2,300 pregnancies each year in the United States (CDC 2004), and more 
than 330,000 babies born globally (Murray et al. 1998). The prevalence of NTDs ranges 
from 0.5 to 2 per 10,000 live births worldwide (Mitchell 2005). Neural tube closure (NTC) 
is the morphological process occurring in early embryogenesis that will ultimately create 
the adult central nervous system including the brain and spinal cord. The initiation of NTC 
involves the elevation of neural folds from the neural plate, ultimately fusing at the dorsal 
midline along the rostral-caudal embryonic axis. The process of NTC is influenced by 
multiple factors including nutrition, environmental factors, and genetics under a complex 
interaction of cellular and molecular mechanisms (Nikolopoulou et al. 2017). NTDs arise 
secondary to a failure of NTC and are classified as either open or closed (Copp & Greene 
2012). Open NTDs include anencephaly, myelomeningocele (spina bifida), and 
craniorachischisis. Fetuses with anencephaly and craniorachischisis die prior to or shortly 
after birth. In closed NTDs, spinal lesions are covered by skin; these include 
lipomyelomeningocele and tethered cord. 
Decades of research has shown that a deficiency of folic acid (FA), together with 
as-yet unknown genetic variants and additional environmental factors, contribute to the 
multifactorial risk of NTDs. Folate is required for multiple cellular processes, including 
nucleotide synthesis, DNA repair, genomic stability, mitochondrial protein synthesis, and 
methylation reactions, including histone methylation (Lucock 2000) (Tibbetts & Appling 
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2010). Over the past 20 years, a vast literature has developed studying the relationship 
between NTDs and the maternal periconceptional consumption of FA, which is the 
synthetic form of folate. The prevalence of NTDs was shown to be significantly reduced 
by up to 70% due to the protective effect of maternal FA supplementation (Czeizel 1998), 
resulting in the recommendation that pregnant women should consume at least 400 μg/day 
(MRC Vitamin Study Research Group 1991). However, there remain a significant number 
of infants born with NTDs that appear to be folate-resistant, as the periconceptional 
administration of FA is unable to prevent all NTDs (Copp, Stanier, and Greene 2013). 
In an effort to identify just how deficiencies in folate metabolism causes NTDs, our 
laboratory has created genetically modified mice with homozygous deletions of critical 
folate transport genes including: the human proton coupled folate transporter (Pcft), the 
bidirectional reduced folate carrier 1 (Rfc1), and the glycosylphosphatidylinositol-
anchored folate receptors (Folr1, Folr2, and Folr4). The monoglutamyl folates are 
absorbed by PCFT that is encoded by SLC46A1 under optimum pH of 5.5 in the small 
intestine. Homozygous Pcft knockout mouse die between 50 and 60 days post-parturition, 
suffering from a hereditary folate malabsorption which produces macrocytic 
normochromic anemia and pancytopenia impaired with erythropoiesis and thrombopoiesis 
(Salojin et al. 2011). RFC1 encoded by SLC19A1 also serves as a monoglutamyl folate 
transporter, resulting in reduced and methylated forms such as 5-methyl-THF (5-mTHF) 
entering into systemic circulation. Homozygous Rfc1 knockout embryos are embryo-lethal 
by E9.5 (Waes et al. 2008), while homozygous knockout Folr1 embryos exhibited embryo-
lethality and folate-responsive cranial NTDs (Piedrahita et al. 1999) (Saitsu 2017). 
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In eukaryotes, folate 1C metabolism occurs in parallel between the cytosol and 
mitochondria. Reduced tetrahydrofolates (THFs) play an important role in folate 1C 
metabolism, as either a 1C donor or acceptor, or transporting 1C groups through reciprocal 
conversions (Tibbetts & Appling 2010). Folate 1C metabolism also supports de novo 
synthesis of purine, thymidylate and homocysteine re-methylation to methionine, 
supporting DNA replication and RNA production. Folate 1C metabolism also regulates 
apoptosis during cell cycle, and plays a role in the epigenetic regulation of DNA 
methylation (Lane & Fan 2015) (Chu & Allegra 1996) (Crider et al. 2012). 
Cytoplasmic folate consisting of the monoglutamate form of THFs, are transported 
into mitochondria by the mitochondrial folate transporter (MFT, encoded by SLC25A32 
gene) localized in the inner mitochondria membrane (Lawrence, Hackett, and Moran 
2011). Mitochondrial folate 1C metabolism is THF-dependent catabolism facilitated by 
mitochondrial THF derived from the cytosol (Tibbetts & Appling 2010). Mitochondrial 
THF carries 1C units to generate CH2-THF from serine catalyzed by the mitochondrial 
enzyme serine hydroxymethyltransferase (SHMT2), producing glycine via the glycine 
cleavage system (GCS). CH2-THF is oxidized to CHO-THF by mitochondrial bifunctional 
CH2-THF dehydrogenase/methenyl-THF cyclohydrolase (MTHFD2, encoded by 
MTHFD2 gene) or mitochondrial CH2-THF dehydrogenase (MTHFD2L, encoded by 
MTHFD2L gene). CHO-THF is a co-substrate to generate formate via the enzyme 
mitochondrial monofunctional 10-formyl-THF synthetase (MTHFD1L, encoded by 
MTHFD1L gene). Formate is the end product of mitochondrial folate metabolism derived 
from mitochondrial THF and is transported into the cytoplasm to provide 1C units 
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necessary for proper nucleotide biosynthesis and methylation reactions (Tibbetts & 
Appling 2010). At least 75% of the 1C units in cytoplasmic folate 1C metabolism are 
derived from the mitochondria (Pike et al. 2010), suggesting that the mitochondrial folate 
transport system plays a critical role in the folate 1C metabolism by transporting THF, a 
carrier of 1C units, in both the cytosol and mitochondria. 
1.1 Folate One Carbon Metabolism 
Folate is an essential B vitamin (B9) that mammalian cells cannot synthesize and 
must be obtained through the diet or via supplementation. For folate to be transported 
within the cell, it must be polyglutamylated by folylpolyglutamate synthase (FPGS), and 
these conjugases are reduced to generate 5,6,7,8-tetrahydrofolate (THF) by dihydrofolate 
reductase (DHFR). The polyglutamate form of folate must be hydrolyzed to a 
monoglutamate for absorption and transport. The THF is a reduced pteridine species 
composed of three chemical moieties; pteridine, p-aminobenzoic acid, and a poly-ɣ-
glutamate tail, and this bioactive form transports 1C units by binding them at N5 and N10 
of the pteridine and p-aminobenzoic acid. A pool of THF coenzymes is linked closely to 
the 1C units, and makes it possible for the THF to participate in various metabolic process 
referred to as 1C metabolism (Tibbetts & Appling 2010). 
As describe in Fig. 1, folate-mediated 1C metabolism occurs in parallel between 
the cytosol and mitochondria in eukaryotes (Barlowe & Appling 1988a). Activated 1C 
units are transported by THF from donors such as serine (García-Martínez & Appling 
1993), glycine (Hampson, Taylor, and Olson 1983), sarcosine (Barlowe & Appling 1988b), 
dimethylglycine or formate between the mitochondria and cytosol (Cybulski & Fisher 
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1977) (Palmieri 2013). In the cytosol, THF generates 5,10-methylene-THF (CH2-THF) by 
accepting 1C of serine from glycolytic intermediates. This serine reaction is processed by 
cytoplasmic serine hydroxymethyltransferase (SHMT1), and its 3-carbon is conveyed to 
THF, producing glycine. Both serine and glycine are transported by the same amino acid 
carrier (García-Martínez & Appling 1993) and serve as 1C donors between the cytosol and 
mitochondria (Yoshida & Kikuchi 1970). Cytoplasmic CH2-THF is a core substance for de 
novo thymidine synthesis, 5-methyl-THF (CH3-THF) formation to homocysteine 
remethylation, and 5,10-methenyl-THF (CH+-THF) conversion. CH2-THF produces CH
+-
THF by the monofunctional NAD-dependent enzyme CH2-THF dyhydrogenase. CH
+-THF 
is oxidized to 10-formyl-THF (CHO-THF) for purine synthesis by CH+-THF 
cyclohydrolase. CHO-THF is converted to THF and formate by the enzyme CHO-THF 
synthetase in an ATP-dependent manner. The reactions described above are catalyzed by 
methylenetetrahydrofolate dehydrogenase (MTHFD1, encoded by the MTHFD1 gene) 
(MacFarlane et al. 2009), trifunctional C1-THF synthase in the cytosol. As mentioned 
above, CH2-THF is reduced to CH3-THF by 5,10-methylene-THF reductase (MTHFR), 
encoded by the MTHFR gene (Ho, Massey, and King 2013) to enter the cytosolic methyl 
cycle. CH3-THF provides the methyl group to homocysteine for methionine synthesis. 
Methionine catalyzes S-adenosyl methionine (SAM) by methionine adenosyl transferase, 
which is subsequently involved in homocysteine re-methylation (Agrimi et al. 2004). 
Ultimately, the cytoplasmic folate-mediated 1C process is important for the de novo 
synthesis of purine and thymidylate, and for homocysteine remethylation to methionine. 
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Mitochondria folate-mediated 1C metabolism parallels the cytosolic pathway. The 
main function of mitochondria folate-mediated 1C metabolism is to supply formate to the 
cytosol for nucleotide biosynthesis and methylation reactions. In mitochondria folate-
mediated 1C metabolism, the cytoplasmic monoglutamate form of THF is transported into 
mitochondria by means of the mitochondrial folate transporter (MFT, encoded by the 
SLC25A32 gene) localized in the inner mitochondria membrane (Palmieri 2013) (Lawrence 
et al. 2011). Mitochondrial THF generates CH2-THF by carrying 1C units from serine with 
SHMT2 (Pfendner & Pizer 1980), producing glycine. Unlike cytoplasmic glycine, 
mitochondrial glycine can transfer 1C units to THF via the GCS (Kikuchi et al. 2008) 
(Lamers et al. 2009). CH2-THF is catalyzed to CH
+-THF by mitochondrial NAD-
dependent CH2-THF dehydrogenase. CH
+-THF is oxidized to CHO-THF by mitochondrial 
CH+-THF cyclohydrolase. These reactions are catalyzed by mitochondrial bifunctional 
CH2-THF dehydrogenase (MTHFD2, encoded by MTHFD2 gene) (Mejia & MacKenzie 
1988) or mitochondrial CH2-THF dehydrogenase (MTHFD2L, encoded by MTHFD2L 
gene) (Shin et al. 2014). CHO-THF is a co-substrate to generate formyl methionine transfer 
RNA (fMet-tRNA) by CHO-THF dehydrogenase, and formate by mitochondrial CHO-
THF synthetase in an ATP-dependent manner, respectively. It is catalyzed by 
mitochondrial monofunctional 10-formyl-THF synthetase (MTHFD1L, encoded by 
MTHFD1L gene (Prasannan et al. 2003) (Prasannan & Appling 2009) (Pike et al. 2010), 
monofunctional C1-THF synthase in the mitochondria. Mitochondrial formate exits to the 
cytoplasm and then contributes to regenerate THF and produce purines (Fig. 1). 
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Previous studies have demonstrated that the MFT protein encoded by SLC25A32 
gene is an exclusive THF transporter from the cytosol to mitochondria (Tibbetts & Appling 
2010) (Ducker & Rabinowitz 2016). The existence of MFT gene was determined from a 
glycine auxotrophy glyB cell derived from Chinese hamster ovary (CHO) cells (Kao, 
Chasin, and Puck 1969). The MFT gene was identified by transduction of a retroviral 
human placental cDNA library into glyB CHO cells shown to be auxotrophic for glycine 
and lacking in mitochondrial folate accumulation (Kao et al. 1969) (Titus & Moran 2000). 
The function of MFT on embryonic development in proper closure of the neural tube in 
mice remains unexplored. 
This study identified a link between the role of the Slc25a32 gene and the 
development of NTDs. To identify the role of the mitochondrial folate transporter during 
embryonic development, we created a new mouse NTD model that lacks a functional 
Slc25a32 gene. The disruption of the Slc25a32 gene results in embryo-fetal lethality, and 
induces morphological abnormalities of NTC in the entire head region of developing 
mouse embryos. The inactivated Slc25a32 embryos express completely penetrant NTDs. 
In this study, we hypothesize that the Slc25a32 gene is associated with the occurrence of 
NTDs because it is essential for THF to participate in the mitochondrial folate 1C 
metabolism. 
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Figure 1. Folate One Carbon (1C) Metabolism 
Reactions from C-1 to C-5 are in the cytoplasm and reactions from M-1 to M-4 are in the 
mitochondrial metabolism. Reactions C-1 and M-1, serine hydroxymethyltransferase; C-2 
and M-2, 5,10-methylene-THF (CH2-THF) dehydrogenase; C-3 and M-3, 5,10-methenyl-
THF (CH+-THF) cyclohydrolase; C-4 and M-4, 10-formyl-THF (10-CHO-THF) 
synthetase; C-5, 5,10-methylene-THF reductase, respectively. The reactions described 
above C-2, C-3, and C-4 are catalyzed by methylenetetrahydrofolate dehydrogenase 
(MTHFD1, encoded by the MTHFD1 gene), trifunctional C1-THF synthase in the cytosol. 
In mitochondria, reactions M-2 and M-3 are catalyzed by methylenetetrahydrofolate 
dehydrogenase (MTHFD2 or MTHFD2L, encoded by MTHFD2 and MTHFD2L genes, 
respectively), bifunctional C1-THF synthase. In mitochondria, CHO-THF is a co-substrate 
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to generate formate by mitochondrial CHO-THF synthetase (M-4). Reaction M-4 is 
catalyzed by methylenetetrahydrofolate dehydrogenase (MTHFD1L, encoded by 
MTHFD1L gene, monofunctional C1-THF synthase in the mitochondria (Tibbetts & 
Appling 2010). 
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2 Materials and Methods 
2.1 Generation of Slc25a32 Mice 
A transgenic mouse model of the gene Slc25a32 was generated by microinjection 
of OmniBank ES cell clones (IST11480G10; encoding the gene Slc25a32) obtained from 
the Texas A&M Institute for Genomic Medicine. The gene trap mutations were produced 
by using the insertion of the gene trap vector, β-geo (LacZ) reporter (encoded by β-
galactosidase) into ES cells derived from the C57BL/6 strain. 
All experimental mice were housed in accordance with guidelines approved by the 
Institutional Animal Care and Use Committee (IACUC) of the University of Texas at 
Austin. Heterozygous Slc25a32+/gt breeding pairs were mated together in order to generate 
embryos of all genotypes. The morning following the introduction of heterozygous 
Slc25a32+/gt males, the Slc25a32+/gt dams aged 8-12 weeks were examined for the presence 
of a vaginal plug, which was indicative of gestational day 0.5 (E0.5). All mice were 
maintained on a PicoLab diet #20 (3 ppm of folic acid) and water, ad libitum, and were 
maintained on a 12-h light/dark cycle in a temperature-controlled room. 
2.2 Embryo Collection and Morphological Evaluation 
Pregnant dams were sacrificed by CO2 asphyxiation and the embryos were removed 
from their decidual capsules and grossly examined under a dissecting microscope (Leica) 
for the presence of NTDs and other morphologic abnormalities. The number of somites 
were determined for each embryo as a hallmark of the development stage of the embryo. 
The crown-rump length (CRL) was quantitatively measured with the aid of dissecting 
microscope. Yolk sacs were collected for DNA extraction and genotyping, after which the 
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embryos were fixed in 10% neutral buffered formalin or stored at -80°C for biochemical 
analyses. 
2.3 Genotyping Assays 
Genomic DNA was extracted from the yolk sacs of embryos or the tail of young 
pups for genotyping assays. The samples were prepared by DirectPCR Lysis Reagent and 
Proteinase K (Viagen Biotech). The PCR genotyping was performed using one primer pair 
(5’-GGTGAAGGAAGGAGGAGCTT-3’ and 5’-TCCACTGTTCAACATTAAGACACA 
-3’) to detect the wild-type allele (266 bp) and the other primer pair (5’-GGTGAAGGAA 
GGAGG3AGCTT-3’ and 5’-CCAATAAACCCTCTTGCAGTTGC-3’) to detect the 
mutant allele (212 bp). 
2.4 β-galactosidase (LacZ) Staining and Histology Analysis 
For detecting reporter gene expression, the β-galactosidase staining of embryos at 
E9.5 was carried out using 5-bromo-4-chloro-3-indolyl-b-galactopyranoside (X-gal) stock 
(Sigma), marking a nuclear localized lacZ transgene. For histological analyses, the E11.5 
fetuses were fixed in 10% neutral buffered formalin and embedded in paraffin. They were 
sectioned at 4-μm thickness and stained with hematoxylin/eosin (HE). 
2.5 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and Quantitative 
Real Time Polymerase Chain Reaction (qRT-PCR) 
For RT-PCR analysis, total mRNA was extracted from whole mouse embryos of 
all Slc25a32 potential genotypes at E10 using TRIzol Reagent (Invitrogen). First-strand 
cDNA was synthesized by cDNA Reverse Transcription Kit (Applied Biosystems). PCR 
was carried out with designed primer pairs of the Slc25a32 gene forward (5’-
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GGAGCCATGACTCTGTGCAT-3’) and reverse (5’-TCCACCGATGCCTTCTTTCC-
3’) to amplify a 441 bp amplicon, and used β-actin primer as a positive control forward 
(5’-CCACCATGTACCCAGGCATT-3’) and reverse (5’-AGGGTGTAAAACGCAGC 
TCA-3’) (253 bp). For qRT-PCR analysis, the total mRNA was prepared from whole E9.5 
embryos of all genotypes and cDNA was synthesized as described above. The mRNA 
levels were quantitatively measured by using SsoAdvanced Universal SYBR Green 
Supermix (Bio-Rad). The Slc25a32 primers and β-actin primers were used as a control, as 
described above. 
2.6 Immunoblot Analysis 
To detect the SLC25A32 protein, mitochondria were isolated from whole E11.5 
fetuses of all three genotypes using the Mitochondria Isolation Kit (Thermo Fisher 
Scientific). The samples were sonicated in RIPA lysis buffer (50mM Tris-HCl pH 8.0, 
150mM NaCl, 0.1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 0.1mM sodium 
orthovanadate, 1mM NaF, and Protease inhibitors tablet (Roche)). A Bradford assay was 
performed to determine the protein concentrations (Bio-Rad). The protein was 
immunoblotted with rabbit polyclonal anti-SLC25A32 (Thermo Fisher Scientific) at a 
concentration of 1:1000, GAPDH (Cell Signaling) as a control at a dilution of 1:5000, and 
1RDye®  800CW Goat anti-Rabbit IgG (LI-COR) at a concentration of 1:10000 to probe 
the antibodies against the target protein. 
2.7 RNA-Sequence Analysis 
Total mRNA was isolated from three E9.0 whole Slc25a32+/+ and Slc25a32gt/gt 
embryos using TRIzol Reagent (Invitrogen), as described above. The concentration of the 
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RNA was determined using a Nanodrop ND-1000 Spectrophotometer (NanoDrop 
Technologies). The integrity of RNA was evaluated using a 1% denaturing RNA gel and 
an Agilent Technologies 2100 Bioanalyzer. Sequencing of the cDNA libraries was carried 
out using the Illumina Hiseq 4000 (Quick Biology). Differentially expressed genes (DEGs) 
were determined by fold change > 1.5 (logFC > 0.58) and a p < 0.05, genes with < 1 count 
per million (cpm). All obtained datasets were analyzed for Gene Ontology (GO), Kyto 
Encyclopedia of Genes and Genomes (KEGG), and reactome analysis with enriched terms, 
and for Ingenuity Pathway Analysis (IPA) including the canonical pathway.  
2.8 Folic Acid and Calcium Formate Supplementation 
Slc25a32+/gt dams were randomly assigned to a control, a folic acid (5-mTHF), and 
a calcium formate supplementation group. The supplementation was administered daily, 
immediately after detection of the vaginal plug (0.5-dpc). In the folic acid group, pregnant 
dams were given 5-mTHF dissolved in distilled water by gavage (25 mg/kg or 50 mg/kg 
body weight). In the calcium formate group, pregnant dams were given 0.1M (2,500 mg) 
calcium formate·kg-1· d-1 by directly in the drinking water based on an average water intake 
of 5 ml/d for a 25 g mouse and were continued throughout pregnancy. 
2.9 Statistical Analysis 
Genotyping frequencies were compared by Hardy-Weinberg equilibrium and 
analyzed using a χ2 test. The data were analyzed by mean ± SE with Stud6ent’s t-test and 
the any p values < 0.05 were considered statistically significant. 
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3 Results 
3.1 Inactivation of Slc25a32 Leads to Embryonic Lethality 
Gene trap insertion of the β-geo reporter locus between exons 1 and 2, resulted in 
a loss-of-function mutation (Fig. 2a). The genotype of Slc25a32 (Fig. 2b) was determined 
by PCR using primers as shown in Fig. 2a. Reverse transcription PCR (RT-PCR) was 
performed to confirm the absence of Slc25a32 mRNA in the Slc25a32gt/gt embryos (Fig. 
3a). The SLC25A32 protein was not detected in isolated mitochondria of the Slc25a32gt/gt 
embryos by immunoblot analysis (Fig. 3b). These data indicate that the homozygous gene 
trap insertion of the Slc25a32 successfully disrupted at both the RNA and protein levels. 
To detect the reporter β-galactosidase (LacZ) gene and determine its expression and 
transfection efficiency, we stained embryos at the beginning of NTC. The activity of β-
galactosidase detected in the Slc25a32gt/gt was compared to the Slc25a32+/+ at E9.5, 
demonstrating that the Slc25a32 message is ubiquitously expressed in the neural tube along 
the entire length of the developing embryo (Fig. 4a). Quantitative real-time PCR (qRT-
PCR) was performed on RNA isolated from the Slc25a32gt/gt and the Slc25a32+/+ E9.5 
embryos to determine the extent of the knockout of the Slc25a32 mRNA caused by 
inserting the gene-trap cassette. The mRNA levels of the Slc25a32gt/gt revealed very little 
expression compared to the Slc25a32+/+, suggesting that the reduced expression of the 
Slc25a32 mRNA contributes to the observed NTDs in the nullizygous embryos (Fig. 4b). 
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Figure 2. Genomic Structure of Slc25a32 gene and Genotype 
Fig. 2a. Genomic Structure of Slc25a32 Gene and Gene Trapping Vector Design. This 
schema illustrates the genomic structure of the Slc25a32 gene. Gene trap insertion of a β-
geo cassette in the Slc25a32 locus between exons 1 and 2. The Slc25a32 gene is disrupted 
by inserting the β-geo (LacZ) that encodes β-galactosidase. The arrows indicate location of 
genotyping forward (F) and reverse (R) primers, wild-type (+/+) and mutant (gt/gt) alleles, 
respectively. LTR: viral long terminal repeat, SA: splice acceptor, pA: polyA. Fig. 2b. 
Genotyping Assays. The extracted genomic DNA is used for PCR genotyping. The banding 
pattern of the PCR products demonstrate the wild-type allele (266 bp) and the mutant allele 
(212 bp). 
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Figure 3. Reverse-Transcriptase (RT)-PCR for mRNA and  
Immunoblot Assay for Protein 
Fig. 3a. RT-PCR for mRNA. Slc25a32 mRNA expression was determined in E10 embryos 
of each possible genotype. Reverse transcription polymerase chain reaction (RT-PCR) 
analysis was performed with Slc25a32, using β-actin primer as a positive control for cDNA 
synthesis. Fig. 3b. Immunoblot Assay for Protein. SLC25A32 protein was detected from 
isolated mitochondria from E11.5 embryos of each potential genotype. The immunoblot 
assay was performed with anti-SLC25A32 antibody and anti-GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) antibody as a loading control. 
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Figure 4. Slc25a32 Gene Expression of β-galactosidase (LacZ) Staining and 
Quantitative Real-Time (qRT)-PCR at E9.5 
Fig. 4a. β-galactosidase (LacZ) Staining at E9.5. Whole mount LacZ staining of 
nullizygous and wild-type embryos at E9.5. β-galactosidase was ubiquitously expressed in 
the Slc25a32gt/gt relative to the Slc25a32+/+ embryos. Fig. 4b. Quantitative Real-time PCR 
(cDNA) at E9.5. The quantitative real-time PCR (qRT-PCR) illustrates mRNA levels of 
Slc25a32 gene expression. The mRNA was reverse transcribed into cDNA from all E9.5 
embryos of all possible genotypes. The qRT-PCR analysis was performed with Slc25a32 
primer and β-actin primer was used as a house-keeping gene. 
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Heterozygous Slc25a32+/gt mice were intercrossed with the intention of generating 
the wild-type (Slc25a32+/+), homozygous mutant (Slc25a32gt/gt) and heterozygous 
(Slc25a32+/gt) mice. We collected a total of 63 litters and 357 live-born young, with an 
average litter size of 5.5 pups per each Slc25a32+/gt dam. Initial breeding of the Slc25a32+/gt 
mice failed to produce any viable live-born Slc25a32gt/gt pups, suggesting that homozygous 
loss of functional Slc25a32 alleles is a lethal mutation. To determine when the Slc25a32gt/gt 
embryos die in utero, the Slc25a32+/gt mice were intercrossed in timed matings, and the 
dams were euthanized between E9.5-12.5 and uterine contents were analyzed. There were 
no Slc25a32gt/gt fetuses beyond E12.5. In total, 271 fetuses were examined between E10-
12.5, in addition to 31 resorptions from 35 litters. The yolk sac of all conceptions were 
used for PCR genotyping. Genotyping indicated there were 76 Slc25a32+/+, 135 
Slc25a32+/gt, and 60 Slc25a32gt/gt fetuses (Table 1). Specifically, 143 embryos between 
E10-10.5 were collected along with 18 resorptions from 18 pregnant dams. There were 43 
Slc25a32+/+, 73 Slc25a32+/gt, and 27 Slc25a32gt/gt embryos. Of 92 embryos collected 
between E11-11.5 were obtained with six resorptions from 12 pregnant dams. There were 
25 Slc25a32+/+, 47 Slc25a32+/gt, and 20 Slc25a32gt/gt embryos. From 5 pregnant dams, 36 
embryos were examined with 7 resorptions and displayed 10 Slc25a32+/+, 14 Slc25a32+/gt, 
and 12 Slc25a32gt/gt embryos between E12-12.5. The genotyping results were consistent 
with a Hardy-Weinberg Equilibrium (p-HWE) (p = 1.00) (Table 1-2). We performed sex-
receptor Y (SRY) genotyping to examine whether disruption of the Slc25a32 gene 
contributed to an increased prevalence of NTD affected male or female embryos. There 
did not appear to be any gender bias in NTD susceptibility (data not shown). The loss of 
 19 
Slc25a32 function results in embryo lethality, demonstrating that the Slc25a32 gene is 
essential during mouse embryonic development. 
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Table 1. The Number of NTDs in Unsupplemented Slc25a32gt/gt Embryos  
at E10-12.5 
p-value of Hardy-Weinberg Equilibrium (p-HWE) 
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Table 2. The p value of Hardy-Weinberg Equilibrium (p-HWE) on Genotype 
Distribution of Unsupplemented Slc25a32 Embryos at E10-12.5 
p-value of Hardy-Weinberg Equilibrium (p-HWE) 
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3.2 Depletion of Slc25a32 Causes a Failure of Neural Tube Closure 
As described above, disruption of the Slc25a32 gene adversely affects early 
embryonic development. All Slc25a32gt/gt fetuses lose viability by E12.5. From the 
Slc25a32+/gt dams, embryos and fetuses from all three potential genotypes were examined 
on different embryonic days to determine the prevalence of NTC defects. All Slc25a32gt/gt 
embryos present with abnormal phenotypes during the period of NTC. They exhibited 
100% penetrant NTDs that were confined primarily to the rostral cranial region, although 
on occasion extending into the cervical or thoracic regions. None of the Slc25a32+/+ and 
Slc25a32+/gt embryos showed NTDs. The majority of NTDs observed in the Slc25a32gt/gt 
embryos at E10.5 were exencephaly, indicating that the fusion of neural tube from the 
forebrain to the midbrain failed to close completely (Fig. 5a). The Slc25a32gt/gt E10.5 
embryos presented with an open neural tube from the forebrain to the hindbrain, as well as 
craniofacial defects (Fig. 5b-c). As shown in Fig. 5d, the Slc25a32gt/gt embryos displayed 
craniorachischisis at E12.5, with an open neural tube extending from the cervical boundary 
to the forebrain. The Slc25a32gt/gt fetuses primarily exhibited exencephaly at E12.5 (Fig. 
5e-f). All Slc25a32gt/gt embryos had open rostral NTDs in the cranial region at E10.5 or 
E12.5. Among 60 Slc25a32gt/gt fetuses evaluated morphologically between E10-12.5, 18 
fetuses had NTC defects from the forebrain to the midbrain, 7 embryos displayed open 
midbrain NTDs, 26 fetuses examined had an open, unfused neural tube extending from the 
midbrain to the hindbrain, and 9 fetuses presented with craniorachischisis. As shown in 
Fig. 6, hematoxylin/eosin (HE) stained histological sections revealed that E11.5 
Slc25a32gt/gt embryos exhibited unfused neural folds at the level of the forebrain and the 
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midbrain (Fig. 6d-e), which was never observed in Slc25a32+/+ embryos (Fig. 6b-c). 
Clearly, a functional deficiency of the Slc25a32 gene resulted in the observed 
dysmorphology and 100% penetrance for NTDs in the mutant mouse. 
Additionally, we observed differences in the developmental growth of the fetuses 
of different Slc25a32 genotypes, most noticeably in the crown-rump measurements after 
NTC at E11.5. As shown in Fig. 7a-b, the Slc25a32gt/gt (2.97 ± 0.26) fetuses were 
significantly smaller than the Slc25a32+/+ (3.97 ± 0.16) at E11.5, suggesting that the 
functional absence of the Slc25a32 gene results in a significant inhibition of embryonic 
growth (p < 0.05). 
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Figure 5. Embryonic NTDs in Unsupplemented Slc25a32gt/gt Embryos  
at E10.5 and E12.5 
Fig. 5a. The Slc25a32gt/gt embryos display open neural tubes from the forebrain to the 
midbrain at E10.5. Arrows indicate unfused neural folds at cranial portion of the 
Slc25a32gt/gt embryos. Fig. 5b and 5c. Arrow indicate that the nullizygous (Slc25a32gt/gt) 
embryos had exencephaly and facial defects at E10.5. Fig. 5d. At E12.5, the Slc25a32gt/gt 
embryos presents with an open neural tube from the forebrain to the hindbrain. Fig. 5e and 
5f. Arrow indicate that the nullizygous (Slc25a32gt/gt) embryos exhibited craniorachischisis 
(5e) and exencephaly (5f) at E12.5. 
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Figure 6. Embryonic Histological Analysis of Slc25a32 Embryos at E11.5 
Fig. 6a. The location of the histological sections of the Slc25a32 embryos at E11.5 is at the 
level of the forebrain and the midbrain. In Fig. 6b and 6c, arrows indicate the Slc25a32+/+ 
embryo with fused neural folds at the level of the forebrain and the midbrain. In Fig. 6d 
and 6e, arrows indicate the Slc25a32gt/gt embryo with unfused neural folds, precursors for 
an exencephaly and facial defects. Scale bars are 1 mm (c and d) and 500 μm (b and e). fb, 
forebrain; mb, midbrain; ne, neuroepithelium 
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Figure 7. Embryonic Crown-rump Length in Unsupplemented Slc25a32 Embryos  
at E11.5 
Fig. 7a. The Slc25a32gt/gt embryos represented an open neural tube and growth retardation 
compared to the Slc25a32+/+ embryos at E11.5. Fig. 7b. The bar chart indicates the 
embryonic crown-rump length differences between the Slc25a32+/+ and the Slc25a32gt/gt 
embryos at E11.5. (*p < 0.05). 
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3.3 Effect of Maternal Folic Acid and Calcium Formate Supplementation in Slc25a32 
Deficient Mouse 
Mitochondrial folate-mediated 1C pathway produces formate to support purine 
biosynthesis. Disruption of the Slc25a32 gene affects the transport of THF into the 
mitochondria and interrupts the generation of formate, which is a downstream output 
product of the mitochondrial folate pathway. The Slc25a32+/gt dams were supplemented 
with either 5-mTHF or calcium formate from the time the pregnancy was recognized (E0.5) 
throughout gestation. The Slc25a32+/gt dams were supplemented with 5-mTHF (25 mg/kg 
or 50 mg/kg body weight) by oral gavage and with 0.1M (a calculated dose of 2,500 
mg/kg/day) calcium formate in their drinking, respectively. The maternal supplementation 
of 5-mTHF in the Slc25a32+/gt dams lose viable Slc25a32gt/gt fetuses by E12.5. With both 
25 mg/kg and 50 mg/kg of 5-mTHF supplementation, we observed 53 fetuses and 4 
resorptions from 6 litters between E10-12.5. Genotyping revealed that there were 12 
Slc25a32+/+, 26 Slc25a32+/gt, and 11 Slc25a32gt/gt fetuses (Table 3). The genotyping results 
were consistent with a Hardy-Weinberg Equilibrium (p-HWE) (p = 0.67) (Table 3-4). All 
of 11 Slc25a32gt/gt fetuses had open NTDs, suggesting that maternal FA (5-mTHF) 
supplementation is not responsive to rescue the NTDs, similar to the unsupplemented 
Slc25a32+/gt mice. The maternal supplementation of calcium formate in the Slc25a32+/gt 
intercrossed mice also failed to generate any viable Slc25a32gt/gt pups, which mirrored our 
experience with the unsupplemented Slc25a32+/gt mouse. By harvesting litters at selected 
timepoints during embryogenesis, we determined that the Slc25a32gt/gt fetuses receiving 
the calcium formate supplementation remain viable until E15.5. In total, we examined 185 
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fetuses between E10-15.5, in addition to 14 resorptions obtained from 23 litters. 
Genotyping revealed that there were 44 Slc25a32+/+, 95 Slc25a32+/gt, and 32 Slc25a32gt/gt 
fetuses (Table 5). The population is in Hardy-Weinberg Equilibrium (p-HWE) (p = 0.13) 
(Table 5-6). With in utero calcium formate supplementation, 25 Slc25a32gt/gt fetuses had a 
normal phenotype and a completely closed neural tube (Fig. 8), while 7 Slc25a32gt/gt fetuses 
had open NTDs (Table 5). This data suggests that 0.1M calcium formate partially rescues 
the NTDs by facilitating the closing of the neural tube in a majority of the Slc25a32gt/gt 
fetuses. 
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Table 3. The Impact of Maternal Folic Acid (5-mTHF) Supplementation on NTC in 
Slc25a32gt/gt Embryos at E10-12.5 
p-value of Hardy-Weinberg Equilibrium (p-HWE) 
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Table 4. The p value of Hardy-Weinberg Equilibrium (p-HWE) on Genotype 
Distribution of Maternal Folic Acid (5-mTHF) Supplemented in Slc25a32 embryos 
at E10-12.5 
p-value of Hardy-Weinberg Equilibrium (p-HWE) 
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Figure 8. Effects of Maternal Calcium Formate Supplementation in Slc25a32gt/gt 
Embryos at E10.5 and E14.5 
The impact of periconceptional calcium formate supplementation on neural tube closure in 
the Slc25a32gt/gt embryos at E10.5 and E14.5. 
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Table 5. The Impact of Maternal Calcium Formate Supplementation on NTC in 
Slc25a32gt/gt Embryos at E10-15.5 
p-value of Hardy-Weinberg Equilibrium (p-HWE) 
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Table 6. The p value of Hardy-Weinberg Equilibrium (p-HWE) on Genotype 
Distribution of Maternal Calcium Formate Supplemented in Slc25a32 embryos at 
E10-15.5 
p-value of Hardy-Weinberg Equilibrium (p-HWE) 
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3.4 RNA-Seq Profiling of Slc25a32 Knockout Embryos at E9.0 
To identify gene dysregulation across the transcriptome following the inactivation 
of Slc25a32, we carried out RNA-seq analysis with three wild-type (Slc25a32+/+) and three 
nullizygous (Slc25a32gt/gt) E9.0 embryos (Fig. 9a). Differential expression analysis 
identified 1,092 genes that were upregulated, while 630 genes were downregulated (Fig. 
10). Of these, the expression level of the Slc25a32 significantly decreased in the 
Slc25a32gt/gt embryos compared with the Slc25a32+/+ embryos (Fig. 9b). Gene ontology 
(GO) analysis revealed enrichment for genes (p < 0.05) involved in blood circulation, 
muscle tissue development, cellular ion homeostasis, regulation of cell morphogenesis, and 
cell fate commitment. The cellular component of GO categories was enriched including 
lytic vacuole, lysosome, cell-cell junction, apical part of cell, and extracellular matrix. 
Among the GO enrichment in molecular function categories, the list included: 
transcriptional activator activity, RNA polymerase II transcription regulatory region 
sequence-specific binding, core promoter proximal region DNA binding, actin binding, 
protein heterodimerization activity, and active transmembrane transporter activity (Fig. 
11). As shown in Table 7, the list revealed multiple dysregulated 1C metabolic process 
genes, as might be expected. The upregulated genes include Fpgs (Folylpolyglutamyl 
synthetase) and Mthfs (5, 10- Methenyltetrahydrofolate synthetase) while downregulated 
genes of interest include Dhfr (Dihydrofolate reductase) and Mthfd2l (Methylene-
tetrahydrofolate dehydrogenase (NADP-dependent) 2-like), both are important enzymes 
involved in folate-mediated 1C metabolism. Among the genes whose transcription was 
significantly altered, there are several genes that have previously been reported to be 
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associated with an increased risk for NTDs, providing validation of our results. Among the 
upregulated genes, these included: cdx2 (caudal type homeobox 2) and Fbln1 (fibulin1), 
both of which are highly expressed and they may be relevant to mediating events during 
NTC (Table 8) (Savory et al. 2011) (Cooley et al. 2008). Several of the most significantly 
downregulated genes include: Lhx9 (LIM homeobox protein 9) and Neurod1 (neurogenic 
differentiation 1) related to neuronal differentiation (Peukert et al. 2011) (Boutin et al. 
2010), Epha3 (Eph receptor A3) associated with epithelial fusion during neural tube 
morphogenesis (Abdul-Aziz et al. 2009) and Pax3 and Zic2 transcription factors (Table 9) 
(Epstein, Vekemans, and Gros 1991) (Carrel et al. 2000) (Ybot-Gonzalez et al. 2007). All 
of these represent interesting candidate genes for future interrogation. Considering the 
ingenuity canonical (IPA) pathway, there are several upregulated or downregulated 
pathways related to the regulation of genes involved in NTC, including upregulation of 
PCP pathway (Wu et al. 2011) and downregulation of Rho family GTPase (Kinoshita et al. 
2008) and RhoA signaling (Nishimura, Honda, and Takeichi 2012) (Fig. 12-13). 
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Figure 9. RNA-Seq Analysis of Inactivation Slc25a32 Gene in Embryos at E9.0 
Fig. 9a. Heat map of RNA-Seq data indicates the differentially expressed genes (DEGs) 
pattern between Slc25a32+/+ (n=3) and Slc25a32gt/gt (n=3) E9.0 embryos. Fig. 9b. RNA-
Seq data shows the expression level of Slc25a32 by normalized reads counts (TMM) in the 
Slc25a32gt/gt embryos compared to the Slc25a32+/+ embryos at E9.0 
 
 
 37 
 
Figure 10. Volcano Plot of RNA-Seq Analysis 
RNA-Seq data identified the upregulated 1,092 genes and the downregulated 630 genes in 
the Slc25a32gt/gt embryos compared to the Slc25a32+/+ embryos at E9.0. 
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Figure 11. Gene Ontology (GO) Enrichment of RNA-Seq Analysis 
RNA-Seq data reveals Gene Ontology (GO) enrichment with the top five classifications 
including; biological process, cellular component, and molecular function in the 
Slc25a32gt/gt embryos compared to the Slc25a32+/+ embryos at E9.0. In bars, the numbers 
represent the numbers of dysregulated genes in each ontological classification (p < 0.05). 
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Table 7. List of Dysregulated One Carbon Metabolic Process Genes in Slc25a32gt/gt 
versus Slc25a32+/+ at E9.0 
FC, fold change; FDR, false discovery rate 
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Table 8. List of Dysregulated Upregulation Genes Associated with NTDs in 
Slc25a32gt/gt versus Slc25a32+/+ at E9.0 
FC, fold change; FDR, false discovery rate 
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Table 9. List of Dysregulated Downregulation Genes Associated with NTDs in 
Slc25a32gt/gt versus Slc25a32+/+ at E9.0 
FC, fold change; FDR, false discovery rate 
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Figure 12. Downregulation of Ingenuity Canonical Pathway in RNA-Seq Analysis 
Ingenuity Canonical Pathway indicates downregulation in the Slc25a32gt/gt embryos 
compared to the Slc25a32+/+ embryos at E9.0. 
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Figure 13. Upregulation of Ingenuity Canonical Pathway in RNA-Seq Analysis 
Ingenuity Canonical Pathway indicates upregulation in the Slc25a32gt/gt embryos compared 
to the Slc25a32+/+ embryos at E9.0. 
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4 Discussion 
Low folate status has been known to increase the risk for an NTD affected 
pregnancy. Studies conducted over the past 30 years have consistently shown that 
periconceptional supplementation with FA can reduce the prevalence of NTDs. While 
maternal FA supplementation may prevent up to 70% of NTDs (MRC Vitamin Study 
Research Group 1991), non-folate responsive NTDs remain a significant health care 
concern. We observed that genetic disruption of Slc25a32 in mice results in NTDs that are 
not responsive to maternal folate supplementation. 
In humans, a SLC25A32 polymorphism in a Japanese population of post-
menopausal women was linked to plasma folate levels and bone fractures. The lower 
plasma folate level is reported in the AA genotype of the rs2241777 SNP in the 3’UTR 
region (Urano et al. 2014). This study demonstrates that gene variants in the mitochondrial 
folate transporter SLC25A32 can impact folate metabolism such that lower concentrations 
are associated with increased risk for skeletal disorders. Clearly, interfering with folate 
transport can have significant impacts on embryonic development and human disease 
states. Our study is based on the association with between SLC25A32 polymorphism and 
folate 1C metabolism regulation and suggests that inactivation of Slc25a32 gene is able to 
impair the mitochondrial folate-mediated 1C metabolism and results in NTDs in mouse. 
Previous investigations have demonstrated that the mitochondrial folate transporter 
encoded by the Slc25a32 gene is located in the inner mitochondrial membrane and 
recognizes THF in mammalian systems (Lawrence et al. 2011) (Titus & Moran 2000). In 
the mitochondria, folate 1C metabolism involves transferring 1C units from donors (Serine, 
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glycine, and formate) to an acceptor (THF). An adequate amount of THF is essential for 
progression of mitochondrial folate 1C catabolism, and the production of formate is 
required for the de novo synthesis of purines and thymidylate in the cytosol (Tibbetts & 
Appling 2010). Several studies have shown that inactivation of folate 1C enzymes leads to 
an increased risk of NTDs as well as embryonic growth retardation. In transgenic mouse 
models lacking functional AMT and Mthfd1l genes, which encode enzymes involved in 
mitochondrial folate 1C metabolism, NTDs are frequent developmental outcomes. 
Aminomethyltransferase (AMT) is one of the GCS components in mitochondria (Narisawa 
et al. 2012). The GCS plays a critical role in mitochondrial folate metabolism by providing 
1C units from glycine to THF, thereby generating CH2-THF. Those fetuses lacking AMT 
had NTDs, confirming the linkage between mitochondrial folate mediated 1C metabolism 
via the GCS, and its deleterious impact on NTC during early embryonic development 
(Narisawa et al. 2012). The Mthfd1l is an monodirectional enzyme that generates formate 
from 10-formyl-THF in the mitochondria to support the cytoplasmic nucleotide 
biosynthesis (Tibbetts & Appling 2010). The Mthfd1l knockout embryos exhibited NTDs 
including exencephaly and craniorachischisis with a wavy neural tube, and a high 
prevalence of embryonic lethality (Momb et al. 2013). In the present study, embryos 
lacking a functional Slc25a32 gene always had an NTD, either exencephaly or 
craniorachischisis, often resulting in embryonic lethality as well, showing the consistent 
neural tube phenotypes with other mouse models that impact mitochondrial 1C 
metabolism. 
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By contrast, inactivation of the cytosolic folate 1C enzymes, Mthfr and Mthfd1, 
does not result in an increased risk for NTDs in the mouse (Copp, Stanier, and Greene 
2013). The enzyme MTHFR encoded by the MTHFR gene is responsible for reduction of 
CH3-THF for the cytosolic methyl cycle (Tibbetts & Appling 2010). The C677T 
polymorphism of MTHFR is linked with NTDs in human (Kirke 2004), while the deletion 
of Mthfr gene in mice resulted in pups who exhibited growth retardation and abnormal lipid 
deposition (Chen et al. 2001), yet failed to express NTDs even among the progeny of 
maternal Mthfr deficient dams maintained on a low folate diet (Li et al. 2005). The enzyme 
MTHFD1, encoded by the MTHFD1 gene is a trifunctional C1-THF synthase required for 
nucleotide biosynthesis in the cytosol (Tibbetts & Appling 2010). The transgenic Mthfdlgt/gt 
embryos often died in utero, demonstrating that Mthfd1 gene is essential for murine 
development. Mthfd1gt/+ dams maintained on a low folate diet produced progeny suffering 
from fetal growth inhibition, although these wild-type and heterozygous offspring did not 
present with NTDs (Beaudin, Perry, et al. 2012). Taken together, these studies suggest that 
inactivation of mitochondrial 1C metabolism has a more severe impact on NTC resulting 
in a very high prevalence of NTDs relative to the many cytoplasmic 1C metabolism 
enzymes that have been knocked out in mutant mice. 
Inactivation of cytosolic enzyme Shmt1 that is required for thymidylate 
biosynthesis and homocysteine remethylation also results in NTD affected embryos in the 
mouse model. The Shmt1-/- embryos displayed exencephaly when the dam was stressed by 
a folate deficient diet, whereas NTDs were not observed when the dams were maintained 
on a folate replete diet (Beaudin, Abarinov, et al. 2012). The Slc25a32gt/gt embryos have an 
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NTD phenotype in spite of the dams being maintained on a standard rodent chow 
containing 3 ppm of FA. Indeed, maternal folate supplementation (5-mTHF) of 
Slc25a32+/gt dams has no beneficial effect in terms of rescuing the normal phenotype in 
Slc25a32gt/gt embryos (Table 3). This is consistent with previously reported results that 
maternal folic acid supplementation was ineffective in reducing the prevalence of NTDs in 
both AMT-/- and Mthfd1lz/z embryos (Momb & Appling 2014). 
We observed that maternal calcium formate supplementation of the Slc25a32+/gt 
dam partially rescues the NTDs in the Slc25a32gt/gt embryos (Fig. 8). Similarly, maternal 
sodium formate supplementation of Mthfd1lz/+ dams significantly reduced the incidence of 
NTDs in the Mthfd1l null embryos, demonstrating that the mitochondrial folate 1C 
metabolism is strongly linked with NTD incidence (Momb et al. 2013). The formate is 
derived from the mitochondrial folate 1C metabolism and the formate status of the embryo 
influences the failure of NTC. This impact appears due to altered de novo purine and 
pyrimidine synthesis that is essential for DNA replication and required during cell 
proliferation (Tibbetts & Appling 2010). In addition, previous studies have shown that 
disruption of purine and thymidylate biosynthesis gives rise to NTD in the mouse, 
demonstrating the importance of purine and thymidylate in NTC (Beaudin et al. 2011) 
(Fleming & Copp 1998). Thus, the rescue of NTDs in the Slc25a32 deficient mouse in 
response to calcium formate supplementation is consistent with the notion that disruption 
of the mitochondrial folate 1C metabolism leads to an increased risk of NTDs. Given the 
mitochondrial nature of the Mthfd1l and Slc25a32 genes, it is not surprising that FA 
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supplementation failed to rescue the phenotype, while exogenous concentrations of the 
calcium formate did provide partial rescue. 
Previous studies have demonstrated that normal mitochondrial function is 
associated with proper folate 1C metabolism. The function of mitochondria is to provide 
ATP production of energy metabolism, mitochondrial respiration, and contribute to glycine 
metabolism. In human cells, mitochondrial respiratory chain dysfunction leads to the 
impairment of the mitochondrial 1C metabolic pathway, demonstrating that inhibition of 
mitochondrial respiratory chain triggered aberrant of serine metabolism (Bao et al. 2016). 
Irregularity of 1C metabolism was linked with mitochondrial DNA (mtDNA) 
hypermethylation resulting in mitochondrial malfunction and leading to impaired 
nucleotide metabolism secondary to mtDNA genomic instability (Desler et al. 2010) (Jia 
et al. 2016). Given that abnormal 1C metabolism could contribute to mitochondrial 
dysfunction, it is possible that lacking a functional Slc25a32 gene increases the risk for 
NTDs in response to either 1C metabolism or mitochondrial dysfunction due to 
mitochondrial THF deficiency. 
Transcriptomic analysis of Slc25a32 embryos identified multiple transcription 
factors and signaling pathways that are critical to the cellular and molecular mechanisms 
involved during normal neural tube development (Table 8-9 and Fig. 12-13). Several 
studies have determined that interaction between transcription factors and signaling 
pathway regulate the morphological movements of neuroepithelial cells, and if aberrant, 
can lead to NTDs (Nikolopoulou et al. 2017). Previously, the transcription factor Pax3 was 
shown to be critical to successful NTC, as inactivating this gene produced embryos with 
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exencephaly (Epstein, Vekemans, and Gros 1991). The Lhx2-Lhx9 deficient zebrafish 
embryos had differentiation defects of thalamic neurons, suggesting that the transcription 
factors Lhx2 and Lhx9 are essential for the development of the caudal forebrain (Peukert et 
al. 2011). Additionally, the Cdx genes encode homeodomain transcription factors, and 
Cdx1-Cdx2 double knockout mutants exhibit a severe form of craniorachischisis. These 
Cdx genes impact NTC by altering the regulation of the planar cell polarity (PCP) 
signaling-related gene Ptk7 (Savory et al. 2011). PCP signaling is one of the key pathways 
involved during early neural tube development, with the role of regulating polarized 
cellular motility of epithelia in a morphogenetic process known as convergent extension 
(Nikolopoulou et al. 2017). The Slc25a32 knockout embryos frequently present with a 
remarkably similar phenotype involving craniorachischisis, and their RNA-seq data clearly 
indicates the down-regulation of the PCP signaling pathway. Indeed, the RNA-seq data of 
Slc25a32 null embryos show an up-regulation of Rho family GTPase and RhoA signaling 
pathway, well-known key signaling pathways involved in NTC (Fig. 13). Activation of 
Rho and Rho-kinase is essential for establishing the shape of the neural plate under apical 
accumulation in neuroepithelial cells (Kinoshita et al. 2008). Taken together, these results 
demonstrate that perturbation of the Slc25a32 gene induces a severe NTD phenotype, 
secondary to dysregulated signaling in the PCP, Rho family GTPase, and RhoA signaling 
pathways which interfere with normal NTC. In gene ontology enrichment, several genes 
were identified in dysregulated biological process including muscle tissue development, 
and regulation of cell morphogenesis including cell-cell junctions in the apical portions of 
the cell (Fig. 11), suggesting the aberrant cellular behavior associated with morphogenetic 
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processes during NTC (Greene & Copp 2014). The RNA-seq data identified several 
dysregulated folate 1C metabolism genes including Fpgs, Mthfs, Dhfr and Mthfd2l (Table 
7), further demonstrating the importance of proper regulation of the folate 1C metabolism 
to proper closure of the neural tube, and how the lack of essential mitochondrial folate 
transport in Slc25a32 nullizygous embryos contribute to their 100% prevalent NTDs. 
In closing, we generated and characterized a novel Slc25a32 knockout mouse 
model that demonstrates the importance of a mitochondrial folate transporter in neural tube 
development. The disruption of the Slc25a32 gene in the mouse results either in fully 
penetrant NTDs, or in embryo-fetal lethality. These results from this study lead us to 
conclude that mitochondrial folate 1C metabolism plays a critical role in promoting normal 
NTC. We believe that a better understanding of the critically important role of 
mitochondrial FA transport and metabolism in NTD susceptibility will help explain the 
beneficial effect that 1C donors have on embryonic development, and provide a pathway 
for developing novel interventions for non-folate responsive NTDs. 
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